sulfinpyrazone has been researched along with Coronary Thrombosis in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shalaev, SV | 1 |
Bokarev, IN | 1 |
Golikov, AP | 1 |
Liusov, VA | 1 |
Ptushkin, VV | 1 |
Zvereva, TV | 1 |
1 review available for sulfinpyrazone and Coronary Thrombosis
Article | Year |
---|---|
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
1 trial available for sulfinpyrazone and Coronary Thrombosis
Article | Year |
---|---|
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
1 other study available for sulfinpyrazone and Coronary Thrombosis
Article | Year |
---|---|
[Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
Topics: Coronary Disease; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Platelet Aggregation; Pl | 1987 |